- $11.12bn
- $14.04bn
- $4.27bn
RCS - Redx Pharma Limited - US FDA lifts Partial Clinical Hold on Zelasudil
AnnouncementRCS - Redx Pharma Limited - Redx Pharma to present new Phase 2a data at ERS
AnnouncementRCS - Redx Pharma Limited - Redx presents Ph1 data supporting RXC008 at DDW
AnnouncementREG - Redx Pharma Limited - Phase 1 Data on RXC008 Presented at ECCO
AnnouncementRCS - Redx Pharma plc - Preclinical Data on RXC008 Presented at UEG Week
AnnouncementRCS - Redx Pharma plc - Redx Reports Encouraging Zamaporvint Phase 2 Data
AnnouncementREG - Redx Pharma plc - Notice of AGM
Announcement